KemPharm (KMPH) Competitor Comparison
We are evaluating the key criteria listed to compare KemPharm (KMPH) against its competitors in the Biotechnology industry.
Market Capitalization
226 / 368Gross Profits
79 / 278Total Revenue
183 / 300EBITDA
74 / 337Free Cashflow
100 / 352Quick Ratio
79 / 357Earnings per Share
121 / 359Dividend yield
0 / 6Total Cash
235 / 358Performance 3 years
56 / 368Performance 5 years
313 / 368Performance 10 years
309 / 368Linearity 3 years
42 / 368Linearity 5 years
299 / 368Linearity 10 years
226 / 368Total Rank
328 / 368Dividend Rank
180 / 368Valuation Rank
211 / 368Piotroski Rank
292 / 368Muliplier Rank
133 / 368Market Capitalization - KMPH ranking 226 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.